Sign In
Buy MRES
$0.0013
+0 (+0%)
At Close: Jun 23, 2026
RLAB & MRES: Tiago Henriques Joins M2MMA Combat Sports Promotion Advisory Board
09:00am, Friday, 24'th Jan 2025
DUBAI, UAE / ACCESS Newswire / January 24, 2025 / Real American Capital Corp (OTC PINK:RLAB), trading as M2MMA, is an avant-garde powerhouse reshaping the combat sports landscape. It is thrilled to an
MRES: Dr. Esmarilda Dankaert Appointed Chief Innovation Officer (CINO) at M2Bio Sciences
09:00am, Monday, 25'th Nov 2024
DUBAI, UAE / ACCESSWIRE / November 25, 2024 / The Institute of Biomedical Research Corp. (OTC PINK:MRES), operating as M2Bio Sciences, is a pioneering biotechnology company dedicated to advancing heal
MRES: M2Bio Food and Beverage Refocuses Strategy: Expanding Beyond CBD to Reach Global Consumers
10:00am, Thursday, 22'nd Aug 2024
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / August 22, 2024 / The Institute of Biomedical Research Corp. (OTC PINK:MRES), a pioneering nutraceutical biotechnology company that delves into the innovative re
RLAB: M2MMA Welcomes Legendary Muay Thai Icon Sagat Petchyindee to Advisory Board!
09:00am, Thursday, 16'th May 2024
DUBAI, UNITED ARAB EMIRATES / ACCESSWIRE / May 16, 2024 / Real American Capital Corp (OTC PINK:RLAB), trading as M2MMA, a leader in mixed martial arts, is thrilled to announce the appointment of Sagat
MRES: M2Bio Food and Beverage Wraps Up 2023/ 2024 Looking Ahead
10:15am, Friday, 22'nd Mar 2024
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / March 22, 2024 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specialising in alter
MRES: M2Bio Sciences Provides Corporate Update
09:10am, Friday, 01'st Mar 2024
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / March 1, 2024 / Institute of Biomedical Research Corporation (OTC PINK:MRES) is pleased to provide further details of the sale to Real American Capital Corporati
MRES: M2Bio Sciences Introduces M2BioKids: A Pioneering Approach to Elevating Childhood Health and Development
09:20am, Friday, 23'rd Feb 2024
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / February 23, 2024 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in al
MRES: M2Enviro 2023 Year-End Review and 2024 Looking Forward
09:15am, Thursday, 22'nd Feb 2024
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / February 22, 2024 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology,specializing in alt
MRES: M2Biome 2023 Year-End Review and 2024 Looking Forward
09:30am, Friday, 09'th Feb 2024
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / February 9, 2024 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in alt
Real American Announces Acquisition of M2MMA from MRES
09:30am, Tuesday, 30'th Jan 2024
PALM SPRINGS, CA / ACCESSWIRE / January 30, 2024 / The Real American Capital Corporation (OTC PINK:RLAB) is pleased to announce the acquisition from Institute of Biomedical Research Corporation (OTC P
Real American Announces Appointment of Officers and Directors
04:55pm, Thursday, 18'th Jan 2024
PALM SPRINGS, CA / ACCESSWIRE / January 18, 2024 / The Real American Capital Corporation (OTC PINK:RLAB) announced today the appointment of Jeff Robinson as Chairman and Director and Willem Jonker as
MRES: M2MMA Gears Up for a Landmark Year in 2024
09:35am, Tuesday, 02'nd Jan 2024
CAPE TOWN / ACCESSWIRE / January 2, 2024 / CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / January 2, 2024 / Institute of Biomedical Research Corp. (OTC PINK: MRES), a vanguard entity at the forefront of nutra
MRES: M2Bio Sciences Expands Global Presence with New Offices in Dubai Science Park
06:30am, Wednesday, 15'th Nov 2023
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / November 15, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES): A pioneering force in nutraceutical biotechnology, specializing in alternative plant-
MRES: M2Bio Sciences Marks Milestone Expansion with Launch of Los Angeles Office
08:00am, Tuesday, 14'th Nov 2023
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / November 14, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology specializing in alt
African Ginger Patented for Influenza and SARS-CoV-2 Treatment: Insights from M2Bio Sciences Research Chair
09:45am, Friday, 03'rd Nov 2023
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / November 3, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology specializing in alte
